S2k guideline: Diagnosis and therapy of localized scleroderma
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-04 · 22 (4) · 605-620
DOI: 10.1111/ddg.15328 ↗Kurz gefasst
Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024-03. Verfasst von Alexander Kreuter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Hospital Oberhausen, Oberhausen, Germany. Hauptthemen laut MEDLINE: Scleroderma, Localized, Dermatologic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The updated S2k guideline deals with the diagnosis and therapy of localized scleroderma (LoS). LoS represents a spectrum of sclerotic skin diseases in which, depending on the subtype and localisation, structures such as adipose tissue, muscles, joints, and bones may also be affected. Involvement of internal organs or progression to systemic sclerosis does not occur. LoS can be classified into four main forms: limited, generalized, linear, and mixed forms, with some additional subtypes. For cases of limited skin involvement, the guideline primarily recommends therapy with topical corticosteroids. UV therapy can also be recommended. In subtypes with severe skin or musculoskeletal involvement, systemic therapy with methotrexate is recommended. During the active phase of the disease, systemic glucocorticosteroids can be used additionally. In cases of methotrexate and steroid refractory courses, contraindications, or intolerance, mycophenolate mofetil, mycophenolic acid, or abatacept can be considered as second‐line systemic therapies. In the case of linear LoS, autologous adipose‐derived stem cell transplantation can also be performed for correcting soft tissue defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Hospital Oberhausen, Oberhausen, Germany.
- Department of Dermatology, Venereology and Allergology, Helios St. Johannes Hospital Duisburg, Duisburg, Germany.
- Department of Dermatology and Venereology, University Hospital Cologne, Cologne, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM),…
- Department of General Pediatrics, Asklepios Hospital, St. Augustin, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
ORCID-Profile: Alexander Kreuter
Zitieren
APA
Kreuter, A., Moinzadeh, P., Kinberger, M., Horneff, G., Worm, M., Werner, R. N., Hammacher, A., Krieg, T., Wenzel, J., Oeschger, M., Weibel, L., Müllegger, R., & Hunzelmann, N. (2024). S2k guideline: Diagnosis and therapy of localized scleroderma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(4), 605-620. https://doi.org/10.1111/ddg.15328
Vancouver
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, et al. S2k guideline: Diagnosis and therapy of localized scleroderma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(4):605-620. doi:10.1111/ddg.15328
BibTeX
@article{Kreuter2024,
author = {Kreuter, Alexander and Moinzadeh, Pia and Kinberger, Maria and Horneff, Gerd and Worm, Margitta and Werner, Ricardo N and Hammacher, Andreas and Krieg, Thomas and Wenzel, Jörg and Oeschger, Michael and Weibel, Lisa and Müllegger, Robert and Hunzelmann, Nicolas},
title = {S2k guideline: Diagnosis and therapy of localized scleroderma},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
volume = {22},
number = {4},
pages = {605--620},
doi = {10.1111/ddg.15328}
}
EUVIMED